Ex-Vivo Expanded Allogeneic γδT Cells (Institute of Hematology & Blood Diseases Hospital)

N/A

Report date: 2024/11/23 20:00:08

Base Information

Drug NameEx-Vivo Expanded Allogeneic γδT Cells (Institute of Hematology & Blood Diseases Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsLymphoma, T-Cell, PeripheralLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesInstitute Of Hematology & Blood Diseases Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitute Of Hematology & Blood Diseases Hospital
Active IndicationsN/A
Inactive IndicationsLymphoma, T-Cell, PeripheralLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A